M&A Lawyers Line Up for Major Pharma Deals

Valeant launched a $45.7 billion hostile takeover bid for Botox-maker Allergan, while Novartis announced a series of transactions with GlaxoSmithKline and Eli Lilly.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.